TABLE 1.
Expt. no.a | Markers | % of T lymphocytes with indicated phenotype
|
|||
---|---|---|---|---|---|
Initial population | Migrated across unstimulated HUVECb | Migrated across IL-1-treated HUVECbc | Migrated across B. burgdorferi-treated HUVECbc | ||
1 | CD45RA−RO+ | 39.3 | 43.2 | 36.4 | 45.7 |
CD45RA+RO− | 36.2 | 5.1 | 4.5 | 5.5 | |
CD45RA+RO+ | 24.0 | 51.5 | 59.0 | 48.6 | |
2 | CD45RA−RO+ | 38.9 | 33.0 | 30.2 | 25.8 |
CD45RA+RO− | 36.2 | 5.5 | 3.3 | 2.8 | |
CD45RA+RO+ | 22.2 | 60.8 | 66.3 | 71.3 | |
3 | CD45RA−RO+ | 23.9 | 25.6 | 31.9 | 31.4 |
CD45RA+RO− | 49.7 | 9.7 | 7.7 | 9.5 | |
CD45RA+RO+ | 17.5 | 62.4 | 59.6 | 58.4 |
Each experiment was performed with T cells isolated from a different donor.
All migratory populations show a significant depletion of CD45RA+RO− T lymphocytes and enrichment for CD45RA+RO+ T lymphocytes compared to the initial population (P < 0.05).
On average, 2.0 ± 0.4-fold more T lymphocytes traversed stimulated HUVEC than unstimulated endothelium in these experiments.